Antipsychotics in pediatric and adolescent patients: A review of comparative safety data

Journal of Affective Disorders

Volumn 138, Issue SUPPL., 2012, Pages

  Ben Amor, Leila ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b Hotel Dieu de Levis Hospital   (Canada)

Author keywords

Antipsychotics; Bipolar disorder; Pediatric; Safety; Schizophrenia; Tolerability

Indexed keywords

ARIPIPRAZOLE; CHOLESTEROL; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; CREATINE KINASE; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; LIVER ENZYME; LOXAPINE SUCCINATE; NEUROLEPTIC AGENT; OLANZAPINE; PROLACTIN; QUETIAPINE; RISPERIDONE; THIORIDAZINE; TIOTIXENE; TRIACYLGLYCEROL; ZIPRASIDONE;

ADOLESCENT HEALTH; AGRANULOCYTOSIS; BIPOLAR DISORDER; BODY MASS; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; DIABETES MELLITUS; DISRUPTIVE BEHAVIOR; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; EXTRAPYRAMIDAL SYMPTOM; EXTRAPYRAMIDAL SYNDROME; FATIGUE; FATTY LIVER; GRANULOCYTOPENIA; HEMATOLOGIC DISEASE; HIGH RISK POPULATION; HUMAN; HYPERPROLACTINEMIA; LIVER FUNCTION TEST; LIVER TOXICITY; LOW DRUG DOSE; METABOLIC DISORDER; MOOD DISORDER; NEUROLEPTIC MALIGNANT SYNDROME; NEUTROPENIA; OBESITY; PEDIATRICS; PRIORITY JOURNAL; PSYCHOSOCIAL DEVELOPMENT; QT PROLONGATION; REVIEW; SAMPLE SIZE; SCHIZOPHRENIA; SEDATION; SEIZURE; SIDE EFFECT; SOMNOLENCE; TARDIVE DYSKINESIA; WEIGHT; WEIGHT GAIN;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CHILD; HUMANS; SAFETY; SCHIZOPHRENIA;

EID: 84858706003     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2012.02.030     Document Type: Review

References (50)

1. C. Arango, M. Parellada, and D.M. Moreno Clinical effectiveness of new generation antipsychotics in adolescent patients European Neuropsychopharmacology 14 Suppl. 4 2004 S471 S479
2. J. Blair, L. Scahill, M. State, and A. Martin Electrocardiographic changes in children and adolescents treated with ziprasidone: a prospective study Journal of the American Academy of Child and Adolescent Psychiatry 44 2005 73 79 (Pubitemid 40019202)
3. S. Caccia, A. Clavenna, and M. Bonati Antipsychotic drug toxicology in children Expert Opinion on Drug Metabolism & Toxicology 7 2011 591 608
4. F. Centorrino, B.H. Price, and M. Tuttle EEG abnormalities during treatment with typical and atypical antipsychotics The American Journal of Psychiatry 159 2002 109 115 (Pubitemid 41070735)
5. K.D. Chang The use of atypical antipsychotics in pediatric bipolar disorder Journal of Clinical Psychiatry 69 Suppl. 4 2008 4 8
6. D. Cohen, and S. Huinink Atypical antipsychotic-induced diabetes mellitus in child and adolescent psychiatry CNS Drugs 21 2007 1035 1038 (Pubitemid 350136785)
7. J.S. Comer, M. Olfson, and R. Mojtabai National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007 Journal of the American Academy of Child and Adolescent Psychiatry 49 2010 1001 1010
8. C.U. Correll Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents The Journal of Clinical Psychiatry 69 Suppl. 4 2008 26 36
9. C.U. Correll, and H.E. Carlson Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents Journal of the American Academy of Child and Adolescent Psychiatry 45 2006 771 791 (Pubitemid 43932904)
10. C.U. Correll, and J.M. Kane One-year incidence rates of tardive dyskinesia in children and adolescents treated with second-generation antipsychotics: a systematic review Journal of Child and Adolescent Psychopharmacology 17 2007 647 656
11. C.U. Correll, P. Manu, V. Olshanskiy, B. Napolitano, J.M. Kane, and A.K. Malhotra Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents JAMA: The Journal of the American Medical Association 302 2009 1765 1773
12. A. Danielyan, and R.A. Kowatch Management options for bipolar disorder in children and adolescents Paediatric Drugs 7 2005 277 294 (Pubitemid 41455885)
13. M. De Hert, V. Schreurs, K. Sweers, D. Van Eyck, L. Hanssens, S. Sinko, M. Wampers, A. Scheen, J. Peuskens, and R. van Winkel Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart review Schizophrenia Research 101 2008 295 303
14. R.L. Findling, V. Kusumakar, D. Daneman, T. Moshang, G. Desmedt, and C. Binder Prolactin levels during long-term risperidone treatment in children and adolescents Journal of Clinical Psychiatry 64 2003 1362 1369 (Pubitemid 37490243)
15. R.L. Findling, H. Steiner, and E.B. Weller Use of antipsychotics in children and adolescents Journal of Clinical Psychiatry 66 Suppl 7 2005 29 40 (Pubitemid 41345492)
16. C. Fleischhaker, P. Heiser, K. Hennighausen, B. Herpertz-Dahlmann, K. Holtkamp, C. Mehler-Wex, R. Rauh, H. Remschmidt, E. Schulz, and A. Warnke Weight gain in children and adolescents during 45 weeks treatment with clozapine, olanzapine and risperidone Journal of Neural Transmission 115 2008 1599 1608
17. D. Fraguas, C.U. Correll, J. Merchán-Naranjo, M. Rapado-Castro, M. Parellada, C. Moreno, and C. Arango Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons European Neuropsychopharmacology 2010 10.1016/j.euroneuro.2010.07.002
18. J. Freedman, W. Wirshing, and A. Russel Absence status seizures after successful long-term clozapine treatment of an adolescent with schizophrenia Journal of Child and Adolescent Psychopharmacology 4 1994 53 62 (Pubitemid 24170579)
19. G. Gerbino-Rosen, D. Roofeh, D.A. Tompkins, D. Feryo, L. Nusser, H. Kranzler, B. Napolitano, A. Frederickson, I. Henderson, J. Rhinewine, and S. Kumra Hematological adverse events in clozapine-treated children and adolescents Journal of the American Academy of Child and Adolescent Psychiatry 44 2005 1024 1031 (Pubitemid 41377558)
20. M. Greenaway, and D. Elbe Focus on aripiprazole: a review of its use in child and adolescent psychiatry Journal of the Canadian Academy of Child and Adolescent Psychiatry 18 2009 250 260
21. M. Haas, M. Eerdekens, L. Kushner, J. Singer, I. Augustyns, J.A. Quiroz, G. Pandina, and V. Kusumakar Efficacy, safety and tolerability of two dosing regimens in adolescent schizophrenia: a double-blind study The British Journal of Psychiatry 194 2009 158 164
22. M. Haas, A.S. Unis, J. Armenteros, M.D. Copenhaver, J.A. Quiroz, and S.F. Kushner A 6-week, randomized, double blind placebo-controlled study of the efficacy and safety of risperidone in adolescent with schizophrenia Journal of Child and Adolescent Psychopharmacology 19 2009 611 621
23. G.A. Keepers, V.J. Clappison, and D.E. Casey Initial anticholinergic prophylaxis for neuroleptic-induced extrapyramidal syndromes Archives of General Psychiatry 40 1983 1113 1117 (Pubitemid 13006227)
24. E. Koller, S. Malozowski, and P.M. Doraiswamy Atypical antipsychotic drugs and hyperglycemia in adolescents JAMA: The Journal of the American Medical Association 286 2001 2547 2548 (Pubitemid 33096804)
25. E.A. Koller, J.T. Cross, and B. Schneider Risperidone-associated diabetes mellitus in children Pediatrics 113 2004 421 422
26. R.A. Kowatch, M. Fristad, B. Birmaher, K.D. Wagner, R.L. Findling, and M. Hellander Treatment guidelines for children and adolescents with bipolar disorder Journal of the American Academy of Child and Adolescent Psychiatry 44 2005 213 235 (Pubitemid 40299835)
27. S. Kumra, J. Frazier, L.K. Jacobsen, K. McKenna, C.T. Gordon, M.C. Lenane, S.D. Hamburger, A.K. Smith, K.E. Albus, J. Alaghband-Rad, and J.L. Rapoport Childhood onset schizophrenia: a double-blind clozapine-haloperidol comparison Archives of General Psychiatry 53 1996 1090 1097 (Pubitemid 26422059)
28. S. Kumra, D. Herion, L.K. Jacobsen, C. Briguglia, and D. Grothe Case study: risperidone-induced hepatotoxicity in pediatric patients Journal of the American Academy of Child and Adolescent Psychiatry 36 1997 701 705 (Pubitemid 27184079)
29. S. Kumra, L.K. Jacobsen, M. Lenane, A. Smith, P. Lee, C.J. Malanga, B.I. Karp, S. Hamburger, and J.L. Rapoport Case series: spectrum of neuroleptic-induced movement disorders and extrapyramidal side effects in childhood-onset schizophrenia Journal of the American Academy of Child and Adolescent Psychiatry 37 1998 221 227 (Pubitemid 28099191)
30. P. Laita, A. Cifuentes, A. Doll, C. Llorente, I. Cortés, M. Parellada, D. Moreno, A. Ruiz-Sancho, M. Graell, and C. Arango Antipsychotic-related abnormal involuntary movements, and metabolic and endocrine side effects in children and adolescents Journal of Child and Adolescent Psychopharmacology 17 2007 487 502
31. A.F. Lehman, J.A. Lieberman, L.B. Dixon, T.H. McGlashan, A.L. Miller, D.O. Perkins, and J. Kreyenbuhl Practice guideline for the treatment of patients with schizophrenia, second edition American Journal of Psychiatry 161 2004 1 56
32. V. Madaan, Y. Dvir, and D.R. Wilson Child and adolescent schizophrenia: pharmacological approaches Expert Opinion on Pharmacotherapy 9 2008 2053 2068
33. G. Masi, and F. Liboni Management of schizophrenia in children and adolescents. Focus on pharmacotherapy Drugs 71 2011 179 208
34. A.K. Mattai, J.L. Hill, and R.K. Lenroot Treatment of early-onset schizophrenia Current Opinion in Psychiatry 23 2010 304 310
35. J. McClellan, R. Kowatch, R.L. Findling, and Work Group on Quality Issues Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder Journal of the American Academy of Child and Adolescent Psychiatry 46 2007 107 125 Erratum in: J. Am. Acad. Child. Adolesc. Psychiatr. 46, 786
36. C. Moreno, G. Laje, and C. Blanco National trends in the outpatient diagnosis and treatment of bipolar disorder in youth Archives of General Psychiatry 64 2007 1032 1039 (Pubitemid 47360848)
37. M. Olfson, C. Blanco, L. Liu, C. Moreno, and G. Laje National trends in the outpatient treatment of children and adolescents with antipsychotic drugs Archives of General Psychiatry 63 2006 679 685 (Pubitemid 43848299)
38. C. Panagiotopoulos, R. Ronsley, and J. Davidson Increased prevalence of obesity and glucose intolerance in youth treated with second-generation antipsychotic medications Canadian Journal of Psychiatry 54 2009 743 749
39. G. Ratzoni, D. Gothelf, A. Brand-Gothelf, J. Reidman, L. Kikinzon, G. Gal, M. Phillip, A. Apter, and R. Weizman Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study Journal of the American Academy of Child and Adolescent Psychiatry 41 2002 337 343 (Pubitemid 38338156)
40. G. Roy, A. Bédard, P.A. Desmarais, F. Jourdain, S. Allen, D. Michaud, and L. Ben Amor Age-dependent metabolic effects of second-generation antipsychotics in second-generation antipsychotic-naive French Canadian patients Journal of Child and Adolescent Psychopharmacology 20 2010 479 487
41. E. Saito, C.U. Correll, K. Gallelli, M. McMeniman, U.H. Parikh, A.K. Malhotra, and V. Kafantaris A prospective study of hyperprolactinemia in children and adolescents treated with atypical antipsychotic agents Journal of Child and Adolescent Psychopharmacology 14 2004 350 358 (Pubitemid 39473121)
42. L. Sikich, R.M. Hamer, R.A. Bashford, B.B. Sheitman, and J.A. Lieberman A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial Neuropsychopharmacology 29 2004 133 145 (Pubitemid 38068023)
43. L. Sikich, J.A. Frazier, J. McClellan, R.L. Findling, B. Vitiello, L. Ritz, D. Ambler, M. Puglia, A.E. Maloney, E. Michael, S. De Jong, K. Slifka, N. Noyes, S. Hlastala, L. Pierson, N.K. McNamara, D. Delporto-Bedoya, R. Anderson, R.M. Hamer, and J.A. Lieberman Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study American Journal of Psychiatry 165 2008 1420 1431
44. R.R. Silva, D.M. Munoz, M. Alpert, I.R. Perlmutter, and J. Diaz Neuroleptic malignant syndrome in children and adolescents Journal of the American Academy of Child and Adolescent Psychiatry 38 1999 187 194 (Pubitemid 29061935)
45. E. Szigethy, M. Wiznitzer, L.A. Branicky, K. Maxwell, and R.L. Findling Risperidone-induced hepatotoxicity in children and adolescents? A chart review Journal of Child and Adolescent Psychopharmacology 9 1999 93 98 (Pubitemid 29379845)
46. I. Tarricone, B. Ferrari Gozzi, A. Serretti, D. Grieco, and D. Berardi Weight gain in antipsychotic-naive patients: a review and meta-analysis Psychological Medicine 40 2010 187 200
47. H. Verdoux, M. Tournier, and B. Begaud Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies Acta Psychiatrica Scandinavica 121 2010 4 10
48. B. Vitiello, C. Correll, B. van Zwieten-Boot, A. Zuddas, M. Parellada, and C. Arango Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns European Neuropsychopharmacology 19 2009 629 635
49. S.W. Woods, A. Martin, S.G. Spector, and T.H. McGlashan Effects of development on olanzapine-associated adverse events Journal of the American Academy of Child and Adolescent Psychiatry 41 2002 1409 1411
50. A. Zuddas, R. Zanni, and T. Usala Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a review of the randomized controlled studies European Neuropsychopharmacology 2011 10.1016/j.euroneuro.2011.04.001